AQUESTIVE THERAPEUTICS INC (AQST)

US03843E1047 - Common Stock

3.365  +0.01 (+0.15%)

After market: 3.37 +0 (+0.15%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
50.58M47.68M50.83M45.85M52.61M
Cost Of Goods
20.83M19.39M14.99M12.96M20.36M
Gross Profit
29.75M28.29M35.84M32.89M32.25M
Operating Expenses
44.85M70.36M70.52M75.78M84.91M
Research and Development
13.10M17.48M17.05M19.89M20.57M
Selling, General, and Administrative Expenses
31.75M52.88M53.48M55.89M64.34M
Operating Income
-15.10M-42.07M-34.68M-42.89M-52.66M
Interest Income/Expense
9.98M-12.34M-22.04M-12.89M-8.68M
Other Income/Expense
-1.13MN/AN/AN/AN/A
Non Recurring Items
-1.38M0.00-13.82M0.00-4.90M
Income Before Taxes
-7.63M-54.41M-70.54M-55.78M-66.25M
Income Tax
245.00K0.000.000.000.00
Net Income
-7.87M-54.41M-70.54M-55.78M-66.25M
EBITDA
-13.76M-39.68M-31.72M-39.45M-49.75M
 
Per Share Data
EPS Diluted Total Ops
-0.13-1.12-1.85-1.66-2.61
Non GAAP EPS
-0.36-1.14-1.49-1.65-2.43
 
Statistics
Gross Profit Margin
58.82%59.33%70.51%71.73%61.30%
Profit Margin
-15.56%-114.11%-138.78%-121.66%-125.93%
Operating Profit Margin
-29.86%-88.23%-68.23%-93.54%-100.10%

All data in USD

Charts